Prevalence and virological features of occult hepatitis B virus infection in female sex workers who work uncontrolled in Turkey

Liver International

Volumn 29, Issue 2, 2009, Pages 227-230

  Pinarbasi, Binnur ^a   Onel, Derya ^a   Cosan, Fulya ^a   Akyuz, Filiz ^a   Dirlik, Nezihe ^b   Cakaloglu, Yilmaz ^a   Badur, Selim ^a   Besisik, Fatih ^a   Demir, Kadir ^a   Okten, Atilla ^a   Kaymakoglu, Sabahattin ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b Istanbul Venereal Diseases Hospital   (Turkey)

Author keywords

Escape mutants; Occult HBV infection; Precore core promoter mutation; S gene mutation

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; VIRUS DNA;

ADULT; ARTICLE; FEMALE; FEMALE SEX WORKER; FEMALE WORKER; GENE MUTATION; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MAJOR CLINICAL STUDY; PREVALENCE; TURKEY (REPUBLIC); VIRUS CORE; VIRUS INFECTION; VIRUS LOAD; VIRUS TRANSMISSION;

ADULT; DNA MUTATIONAL ANALYSIS; DNA PRIMERS; FEMALE; GENOTYPE; HEPATITIS B; HEPATITIS B ANTIGENS; HEPATITIS B VIRUS; HUMANS; PREVALENCE; PROSTITUTION; TURKEY;

EID: 58149498799     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2008.01809.x     Document Type: Article

References (27)

1. Conjewaram HS, Lok AS. Occult hepatitis B virus infection: A hidden menace? Hepatology 2001; 34: 204-6.
2. Chemin I, Trepo C. Clinical impact of occult HBV infections. J Clin Virol 2005; 34 (Suppl. 1): S15-21.
3. Hu KQ. Occult hepatitis B virus infection and its clinical implications. J Viral Hepat 2002; 9: 243-57.
4. Kim SM, Lee KS, Park CJ, et al. Prevalence of occult HBV infection among subjects with normal serum ALT levels in Korea. J Infect 2007; 54: 185-91.
5. Shih LN, Sheu JC, Wang JT, et al. Serum hepatitis B virus DNA in healthy HBsAg-negative Chinese adults evaluated by polymerase chain reaction. J Med Virol 1990; 32: 257-60.
6. Fang ZL, Zhuang H, Wang XY, et al. Hepatitis B virus genotypes, phylogeny and occult infection in a region with a high incidence of hepatocellular carcinoma in China. World J Gastroenterol 2004; 10: 3264-8.
7. Lo YM, Lo ES, Mehal WZ, et al. Geographical variation in prevalence of hepatitis B virus DNA in HBsAg negative patients. J Clin Pathol 1993; 46: 304-8.
8. Cacciola I, Pollicino T, Squadrito G, Cerenzia G, Orlando ME, Raimondo G. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. N Engl J Med 1999; 341: 22-6.
9. Mrani S, Chemin I, Menouar K, et al. Occult HBV infection may represent a major risk factor of non-response to antiviral therapy of chronic hepatitis C. J Med Virol 2007; 79: 1075-81.
10. Re VL III, Frank I, Gross R, et al. Prevalence, risk factors, and outcomes for occult hepatitis B virus infection among HIV-infected patients. J Acquir Immune Defic Syndr 2007; 44: 315-20.
11. Takeuchi M, Fujimoto J, Niwamoto H, et al. Frequent detection of hepatitis B virus X-gene DNA in hepatocellular carcinoma and adjacent liver tissue in hepatitis B surface antigen-negative patients. Dig Dis Sci 1997; 42: 2264-9.
12. Besisik F, Karaca C, Akyuz F, et al. Occult HBV infection and YMDD variants in hemodialysis patients with chronic HCV infection. J Hepatol 2003; 38: 506-10.
13. Toyoda H, Hayashi K, Yoshiki M, et al. Prevalence and clinical implications of occult hepatitis B viral infection in hemophilia patients in Japan. J Med Virol 2004; 73: 195-9.
14. Hui CK, Sun J, Au WY, et al. Occult hepatitis B virus infection in hematopoietic stem cell donors in a hepatitis B virus endemic area. J Hepatol 2005; 42: 813-9.
15. Sakarya S, Oncu S, Ozturk B, Oncu S. Effect of preventive applications on prevalence of hepatitis B virus and hepatitis C virus infections in West Turkey. Saudi Med J 2004; 25: 1070-2.
16. Gurol E, Saban C, Oral O, Cigdem A, Armagan A. Trends in hepatitis B and hepatitis C virus among blood donors over 16 years in Turkey. Eur J Epidemiol 2006; 21: 299-305.
17. Weinberger KM, Bauer T, Bohm S, et al. High genetic variability of the group-specific a-determinant of hepatitis B virus surface antigen (HBsAg) and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum. J Gen Virol 2000; 81: 1165-74.
18. Saito T, Shinzawa H, Uchida T, et al. Quantitative DNA analysis of low-level hepatitis B viremia in two patients with serologically negative chronic hepatitis B. J Med Virol 1999; 58: 325-31.
19. Kobayashi M, Arase Y, Ikeda K, et al. Precore wild-type hepatitis B virus with G1896 in the resolution of persistent hepatitis B virus infection. Intervirology 2003; 46: 157-63.
20. Chu CM, Hung SJ, Lin J, et al. Natural history of hepatitis B e antigen to antibody seroconversion in patients with normal serum aminotransferase levels. Am J Med 2004; 116: 829-34.
21. Duong TN, Horiike N, Michitaka K, et al. Comparison of genotypes C and D of hepatitis B virus in Japan: A clinical and molecular biological study. J Med Virol 2004; 72: 551-7.
22. Fung SK, Lok AS. Hepatitis B virus genotypes: Do they play a role in the outcome of HBV infection? Hepatology 2004; 40: 790-2.
23. Jilg W, Sieger E, Zachoval R, et al. Individuals with antibodies against hepatitis B core antigen as the only serological marker for hepatitis B infection: High percentage of carriers of hepatitis B and C virus. J Hepatol 1995; 23: 14-20.
24. Paterlini P, Gerken G, Nakajima E, et al. Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancers from patients negative for hepatitis B surface antigen. N Engl J Med 1990; 323: 80-5.
25. Torbenson M, Thomas DL. Occult hepatitis B. Lancet Infect Dis 2002; 2: 479-86.
26. Fukuda R, Ishimura N, Kushiyama Y, et al. Hepatitis B virus with X gene mutation is associated with the majority of serologically "silent" non-b, non-c chronic hepatitis. Microbiol Immunol 1996; 40: 481-8.
27. Prince AM, Stephan W, Brotman B. Beta-propiolactone/ultraviolet irradiation: A review of its effectiveness for inactivation of viruses in blood derivatives. Rev Infect Dis 1983; 5: 92-107.